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TO THE EDITOR
When a clinically suspicious pigmented lesion is biopsied and histologic examination shows 
melanoma, tumor depth, or Breslow’s depth (BD), is the key parameter that both determines 
surgical margins for definitive excision and serves as an indication to perform sentinel 
lymph node biopsy (Smith and MacNeil, 2011). Optimally, BD is measured during an initial 
excisional biopsy that includes the entire lesion. However, in many cases an incisional 
biopsy is performed that takes a sample of only a portion of the tumor, possibly resulting in 
an inaccurate measurement (Guitera and Menzies, 2011; Sellheyer et al., 2010). Wide local 
excision based on a potentially inaccurate BD may be insufficient to adequately treat the 
tumor, necessitating a second definitive surgery. Thus, a precise in vivo measurement of 
tumor depth would facilitate appropriate surgical treatment at the time of wide local excision 
when only a partial biopsy sample has been obtained.
In this work, we propose applying photoacoustic tomography (PAT) to address this problem. 
Compared with traditional optical imaging methods, PAT uses ultrasonic waves, which give 
approximately 1,000 times less scattering than optical waves, breaking through the optical 
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diffusion limit (~1 mm in the skin) for penetration (Wang and Hu, 2012; Wang and Gao, 
2014). In addition, by using optical excitation of acoustic waves due to light absorption, PAT 
provides improved contrast of melanin, which is deficient in ultrasonographic imaging. In 
previous mouse models, we measured a melanoma greater than 7 mm in depth (Zhou et al., 
2015). Here we extend our work to patients with melanoma, with the aim of determining the 
accuracy of PAT-measured melanoma depth compared with the actual BD based on 
excisional biopsy results. In addition, we also compare our PAT measurement with the 
histologic measurement obtained from partial incisional biopsy to ultimately determine the 
predictability and application of PAT measurements in a clinical setting.
We applied a linear array-based handheld photoacoustic probe (Figure 1) (LZ250, 
Visualsonics Inc., Toronto, Ontario, Canada) for melanoma imaging in patients (Hai et al., 
2015; Needles et al., 2013). The transducer array has 256 elements with a size of 23 mm × 3 
mm. Each element in the array is cylindrically focused at 15 mm distance. With a central 
frequency of 21 MHz and a 70% one-way bandwidth, the probe provides spatial resolutions 
of 1,237 μm, 119 μm, and 86 μm in the elevational, lateral, and axial directions, respectively 
(Zhou et al., 2015). For the highest melanoma detection sensitivity, pulse-light at 680 nm 
illuminates the target, where blood has low absorption (Yao and Wang, 2014). The optical 
fluence on the skin surface is approximately 10 mJ/cm2, which is less than the safety limit 
set by the American National Standards Institute (20 mJ/cm2) at this wavelength.
Our study was approved by the Institutional Review Board of Washington University in St. 
Louis (IRB ID#: 201410125). Ten patients were recruited, and 13 lesions were imaged. 
Benefits and risks of the study were explained to the patients in detail, and written consent 
was obtained. We initially performed PAT imaging of the melanomas using our handheld 
probe followed by an excisional biopsy to determine the BD of each melanoma. Of the 13 
lesions that were imaged, six presented after an initial incisional biopsy, providing a 
provisional BD (pBD) before PAT imaging (See Supplementary Table S1 and S2 online). 
After imaging and histologic examination, we determined that one lesion was composed 
entirely of melanophages with no tumor cells, and another amelanotic tumor extended to a 
depth (>10 mm) that was beyond the maximum imaging capacity of the PAT probe, although 
the most superficial portion of the tumor could be detected. A third patient who presented 
with widely metastatic disease received systemic therapy at an outside institution before 
wide local excision of his primary lesion. Thus, we excluded the lesions from these three 
patients from our final data analysis.
PAT images from a cutaneous melanoma metastasis on the left lower extremity (Figure 2a) 
and a primary cutaneous acral lentiginous melanoma (Figure 2d) clearly show the ability of 
PAT to detect dermal and epidermal melanin-containing components of the tumors, allowing 
for direct in vivo measurement of melanoma depth. (PAT measurement was adjusted by a 
factor of 0.88 to account for ex vivo tissue fixation and processing [Winsor, 1994], and this 
is indicated as corrected [cPA] depth.) Immediately after imaging, an excisional biopsy was 
performed and actual BD was determined (Figure 2c and f). As shown in Figure 2a–c, the 
cutaneous melanoma metastasis PAT depth in vivo (cPA) is concordant with the actual BD. 
Similarly, the primary tumor cPA measurment more closely represented the acutal BD than 
the pBD obtained from a partial biopsy (Figure 2d–f).
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The depth of all of the tumors that were successfully imaged ranged between 0.2 mm and 
6.0 mm (Figure 2g). cPA depths are concordant with actual BD obtained after excisional 
biopsy (mean absolute error (MAE) = 0.18 mm; R2 = 0.97). When comparing cPA obtained 
by PAT with the actual BD in the five patients with primary melanomas who had incisional 
biopsy before PAT, PAT achieved accurate measurements (MAE = 0.14 mm). Comparing 
cPA measurement with the incisional biopsy pBD is less concordant, as might be expected 
(MAE = 0.21 mm). Thus, in our pilot study, PAT was accurate in determining BD in 
melanoma and was an effective imaging tool that accurately determined melanoma depth to 
potentially guide definitive surgical intervention.
In this pilot study with a limited number of patients, PAT did not alter but rather confirmed 
current surgical treatment based on pBD, particularly for standard pigmented melanomas 
compared with amelanotic melanomas. PAT provided an accurate measurement of 
melanoma depth as determined by BD measurement of the residual tumor on excisional 
biopsy. We acknowledge that melanomas with a depth of 10 mm or greater were beyond the 
detection limit of our current system because of strong light attenuation resulting in weak 
signal. Although we have addressed this technical problem in previous systems (Zhou et al., 
2014), this technology was not incorporated into our non-handheld prototype because of the 
technical design of the probe. In this current handheld system, we conclude that PAT 
technology is noninvasive, provides high contrast for melanoma imaging with detection 
capabilities, and adapts easily to bedside monitoring, providing information that may 
potentially facilitate early and effective surgical intervention.
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Zhou et al. Page 3
J Invest Dermatol. Author manuscript; available in PMC 2018 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
References
Guitera P, Menzies SW. State of the art of diagnostic technology for early-stage melanoma. Expert Rev 
Anticanc. 2011; 11:715.
Hai P, Zhou Y, Liang J, Li C, Wang LV. Photoacoustic tomography of vascular compliance in humans. 
J Biomed Opt. 2015; 20(12):126008. [PubMed: 26720875] 
Needles A, Heinmiller A, Sun J, Theodoropoulos C, Bates D, Hirson D, Yin M, Foster FS. 
Development and initial application of a fully integrated photoacoustic micro-ultrasound system. 
IEEE Trans Ultrason Ferroelectr Freq Control. 2013; 60:888–97. [PubMed: 23661123] 
Sellheyer K, Nelson P, Bergfeld WF. Inadequate biopsy technique and specimen size: an alarming 
tread that compromises patient care and an appeal to our clinical colleagues. Arch Dermatol. 2010; 
146:1180–1. [PubMed: 20956663] 
Smith L, MacNeil S. State of the art in non-invasive imaging of cutaneous melanoma. Skin Res 
Technol. 2011; 17:257. [PubMed: 21342292] 
Wang LV, Hu S. Photoacoustic tomography: in vivo imaging from organelles to organs. Science. 2012; 
335(6075):1458–62. [PubMed: 22442475] 
Wang LV, Gao L. Photoacoustic microscopy and computed tomography: from bench to bedside. Annu 
Rev Biomed Eng. 2014; 16:155–85. [PubMed: 24905877] 
Winsor, L. Tissue processing. In: Woods, A., Ellis, R., editors. Laboratory histopathology. New York: 
Churchill Livingstone; 1994. p. 1-39.
Yao J, Wang LV. Sensitivity of photoacoustic microscopy. Photoacoustics. 2014; 2:87–101. [PubMed: 
25302158] 
Zhou Y, Li G, Zhu L, Li C, Cornelius LA, Wang LV. Handheld photoacoustic probe to detect both 
melanoma depth and volume at high speed in vivo. J Biophotonics. 2015; 8:961–7. [PubMed: 
25676898] 
Zhou Y, Xing W, Maslov KI, Cornelius LA, Wang LV. Handheld photoacoustic microscopy to detect 
melanoma depth in vivo. Opt Lett. 2014; 39:4731–4. [PubMed: 25121860] 
Zhou et al. Page 4
J Invest Dermatol. Author manuscript; available in PMC 2018 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. Photoacoustic system for imaging in melanoma patients
(a) Schematic of the photoacoustic system. DAQ, data acquisition system; FC, fiber coupler; 
L1 and L2, lenses; M1 and M2, mirrors; ND, neutral density filter; PL, pump laser; TL, 
tunable laser. (b) Absorption spectra of melanin and blood at typical concentrations in tissue. 
A wavelength of 680 nm was chosen for melanoma imaging, at which the absorption ratio 
between melanin and blood is relatively high.
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Figure 2. PAT-based depth is more accurate than the provisional incisional biopsy depth (pBD)
PAT of melanoma two patients: (a–c) a patient with cutaneous melanoma metastases on the 
left lower extremity and (d–f) a patient with primary acral lentiginous melanoma on the right 
foot. (a) Melanoma image acquired with PAT, clearly showing the melanoma and skin 
surface with a PA depth of 1.9 mm (cPA depth = 1.67 mm). Scale bar = 1 mm. (b) 
Cutaneous melanoma metastasis in a patient’s lower leg. (c) Histology of the excised 
melanoma, showing actual BD of 1.67 mm. Original magnification ×40. Scale bar = 1 mm. 
(d) PAT melanoma image of the acral lentiginous melanoma with PA depth of 0.70 mm (cPA 
depth = 0.62 mm). Scale bar = 1 mm. (e) Acral lentiginous melanoma (data not shown: pBD 
= 0.48 mm). (f) Histology after complete excision, actual BD of 0.78 mm. Original 
magnification ×100. Scale bar = 0.5 mm. (g) cPA depth (red circles) and pBD (blue squares) 
plotted against actual BD. Blue line shows 1:1 concordance of PAT measurements (cPA) if 
identical to the actual BD after excision. Inset graph shows cPA (red circles) and pBD (blue 
squares) plotted against a 1:1 concordance of pBD to actual BD (black line). BD, Breslow’s 
depth; cPA, corrected photoacoustic tomography; PAT, photoacoustic tomography; pBD, 
provisional Breslow’s depth.
Zhou et al. Page 6
J Invest Dermatol. Author manuscript; available in PMC 2018 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
